| DOXGX | IPFPX | DOXGX / IPFPX | |
| Total Expense Ratio | 0.41 | 0.96 | 43% |
| Annual Report Gross Expense Ratio | 0.46 | 1.07 | 43% |
| Fund Existence | 4 years | 16 years | - |
| Gain YTD | 2.230 | 4.039 | 55% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 119B | 337M | 35,312% |
| Annual Yield % from dividends | 1.38 | 1.64 | 85% |
| Returns for 1 year | 5.87 | 17.79 | 33% |
| Returns for 3 years | 26.04 | 15.42 | 169% |
| Returns for 5 years | N/A | 32.16 | - |
| Returns for 10 years | N/A | 79.04 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MDSKX | 28.55 | 0.20 | +0.71% |
| iShares Russell 2000 Small-Cap Idx Inv A | |||
| LRSYX | 21.18 | 0.12 | +0.57% |
| Lord Abbett Small Cap Value I | |||
| SMVZX | 12.77 | 0.01 | +0.08% |
| Virtus Ceredex Mid-Cap Value Equity R6 | |||
| LVFLX | 16.04 | 0.01 | +0.06% |
| Lord Abbett Focused Large Cap Value R6 | |||
| JUEPX | 26.69 | -0.23 | -0.85% |
| JPMorgan US Equity R3 | |||